Rare diseases
Investigational molecules
Locations
Back to Slovakia30 clinical trials in Piestany, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
SlovakiaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
SlovakiaStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
SlovakiaStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
SlovakiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
SlovakiaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
SlovakiaEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
SlovakiaEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
SlovakiaPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
SlovakiaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
SlovakiaStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
SlovakiaStudy on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials investigating treatments for systemic lupus erythematosus, cutaneous lupus, and primary Sjögren's syndrome. Research focuses on developing targeted therapies to manage symptoms and improve patient outcomes.
Studies evaluate new biological treatments and their long-term safety profiles.
Groundbreaking studies examining innovative treatments for atherosclerotic cardiovascular disease and atrial fibrillation. Trials focus on preventing major cardiovascular events and managing stroke risk.
Research aims to reduce cardiovascular mortality and improve treatment outcomes.
Clinical investigations targeting rheumatoid arthritis, psoriatic arthritis, and rotator cuff tendinopathy. Studies evaluate new therapeutic approaches for inflammatory joint conditions.
Research focuses on improving mobility and reducing disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
